Whitney Ijem

Sep 04, 2026

Whitney Ijem rated BLTE as Buy on Sep 04, 2026, setting a price target of 303. Shares have remained stable near 171.09, leaving the 303 target still in play.

Aug 20, 2026

On Aug 20, 2026, RARE was given a Buy rating by Whitney Ijem, with a target price of 83. Despite the Buy call, shares fell from 14.85 to 14.85, challenging the optimistic stance.

Aug 03, 2026

On Aug 03, 2026, Whitney Ijem published a Buy outlook on PHAR, with a target of 38. Shares gained 16.70%, underscoring the accuracy of the bullish outlook toward 38.

Jul 28, 2026

Whitney Ijem on Jul 28, 2026 assigned TENX a Buy rating, with a price target of 35. The call has struggled to gain traction, with shares losing 88.73%.

Jun 16, 2026

On Jun 16, 2026, Whitney Ijem reaffirmed RYTM with a Buy rating, targeting 151. The recommendation was supported by strong follow-through as the stock rose from 104.89 to 104.89.

Jun 16, 2026

NTLA was rated Buy by Whitney Ijem on Jun 16, 2026, with a price objective of 49. This case shows how bullish projections can fail, with the stock now below 12.68.

Jun 03, 2026

On Jun 03, 2026, Whitney Ijem initiated coverage on BBIO with a Buy rating and target of 104. The stock’s climb of 15.16% since the call highlights the foresight in the rating.

May 27, 2026

Whitney Ijem issued a Buy recommendation for OCGN on May 27, 2026, price target set at 11. The target of 11 remains in play, though confirmation will depend on future moves.

May 22, 2026

On May 22, 2026, BMRN was evaluated by Whitney Ijem, who gave a Buy rating and target of 111. This case illustrates how a timely bullish rating can translate into tangible gains of 22.81%.

Apr 30, 2026

Whitney Ijem rated WVE as Buy on Apr 30, 2026, setting a price target of 43. The stock has underperformed, dropping 33.43% despite the bullish target of 43.

Apr 06, 2026

On Apr 06, 2026, TSHA was given a Buy rating by Whitney Ijem, with a target price of 17. The stock rallied 19.78% after the rating, narrowing the gap to the target of 17 and validating the bullish stance.

Apr 06, 2026

NGNE received a Buy rating from Whitney Ijem on Apr 06, 2026, aiming for 180. Momentum has favored the Buy call, with shares climbing from 37.61 to 37.61, rewarding those who trusted the recommendation.

Mar 26, 2026

On Mar 26, 2026, Whitney Ijem published a Buy outlook on GUTS, with a target of 8. So far, the stock has neither confirmed nor rejected the Buy case, holding within range of 0.6873.

Mar 05, 2026

Whitney Ijem on Mar 05, 2026 assigned ARCT a Buy rating, with a price target of 66. The recommendation remains pending validation as shares consolidate around 15.56.

Mar 04, 2026

On Mar 04, 2026, Whitney Ijem reaffirmed PASG with a Buy rating, targeting 67. Market indecision has kept the 67 target in a holding pattern.

Feb 20, 2026

BEAM was rated Buy by Whitney Ijem on Feb 20, 2026, with a price objective of 74. A bullish response from the market helped close the gap of 44.54 to the target.

Feb 17, 2026

On Feb 17, 2026, Whitney Ijem initiated coverage on ALNY with a Buy rating and target of 429. The Buy call has yet to be validated as shares remain 164.50 away from the target.

Dec 18, 2025

Whitney Ijem issued a Buy recommendation for TNYA on Dec 18, 2025, price target set at 6. The target of 6 remains in play, though confirmation will depend on future moves.

Dec 16, 2025

On Dec 16, 2025, PVLA was evaluated by Whitney Ijem, who gave a Buy rating and target of 204. This case illustrates how a timely bullish rating can translate into tangible gains of 60.59%.

Aug 18, 2025

Whitney Ijem rated GBIO as Buy on Aug 18, 2025, setting a price target of 10. The stock has underperformed, dropping 19.46% despite the bullish target of 10.

Jul 25, 2025

On Jul 25, 2025, RCKT was given a Buy rating by Whitney Ijem, with a target price of 10. The stock rallied 20.70% after the rating, narrowing the gap to the target of 10 and validating the bullish stance.

Mar 17, 2025

On Mar 17, 2025, Whitney Ijem published a Buy outlook on RGLS, with a target of 28. Shares gained 495.62%, underscoring the accuracy of the bullish outlook toward 28.